ALK and non-small cell lung carcinoma: Vanderlaan et al. reported that the accuracy of molecular analysis using PCNB samples was lower than noted in a previous study [31]; the accuracies of EGFR mutational and ALK FISH tests performed on PCNB samples were 68% and 65%, respectively, in 22 patients with NSCLC.